Back

Prognostic value of cardiac metabolic activity assessed by 18F-FDG PET in patients with cardiac sarcoidosis

2 September 2019 (14:47 - 14:56)
Organised by:
Congress Presentation Part of: Multimodality imaging in cardiomyopathy Positron Emission Tomography (PET) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Yuta Kobayashi

Hokkaido University, Sapporo (Japan)

7 More presentations in this session

Presentation thumbnail
Functional assessment of the myocardium in non-ischaemic cardiomyopathy using manganese-enhanced T1 mapping
Doctor M. Dweck (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Diagnostic specificity of triangular basal inferoseptal late gadolinium enhancement for identification of cardiac sarcoidosis
Doctor L. Kuo (Taipei, TW)
Abstract
Presentation thumbnail
Maximum standardized uptake value of pericardial fat for prediction of ventricular arrhythmias in patients with cardiac sarcoidosis
Doctor Y. Ishii (Oita, JP)
Abstract
Presentation thumbnail
Mechanical dispersion by speckle tracking echocardiography in fabry disease
Professor T. Cianciulli (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Magnetic resonance imaging of Fabry disease cardiomyopathy in patients receiving oral chaperone therapy
Doctor J. Muentze (Wuerzburg, DE)
Abstract

Access the full session

Session thumbnail
Multimodality imaging in cardiomyopathy

The Event

Event poster

ESC Congress 2019

2 September 2019 14:47 CET
You may be interested in
thumbnail
Congress Presentation
Total-body PET: what is it and what might it offer?
thumbnail
Congress Presentation
Total-body positron emission tomography/CT in cardiology: are we ready for it? - discussion
thumbnail
Congress Presentation
What comes next in nuclear cardiology?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources